EUVIMEDEUVIMED entdecken
Crossref

Lung Cancer Patients' Cognitive Impairment: Assessment Tools and Key Influencing Factors

Healthcare and Nursing Practice · 2026 · 2 (2)

DOI: 10.47297/ppihnp2026020205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Healthcare and Nursing Practice, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-related cognitive impairment (CRCI) is one of the most common central nervous system complications in patients with lung cancer during anti-tumor treatment. It not only reduces patients' motivation to participate in medical decisionmaking and adhere to treatment regimens but also severely impairs their daily living functions, health-related quality of life, and long-term treatment prognosis. This narrative review summarizes the research progress regarding assessment tools and influencing factors of CRCI in patients with lung cancer, with the aim of providing evidence for the development of individualized and multi-dimensional cognitive protection programs and targeted intervention strategies in clinical practice. Ultimately, this work is expected to further promote the continuous optimization of the overall rehabilitation quality of patients with lung cancer.

Zitieren

APA

(2026). Lung Cancer Patients' Cognitive Impairment: Assessment Tools and Key Influencing Factors. Healthcare and Nursing Practice, 2(2). https://doi.org/10.47297/ppihnp2026020205

Vancouver

Lung Cancer Patients' Cognitive Impairment: Assessment Tools and Key Influencing Factors. Healthcare and Nursing Practice. 2026;2(2). doi:10.47297/ppihnp2026020205

BibTeX
@article{euvimed2026,
  title = {Lung Cancer Patients' Cognitive Impairment: Assessment Tools and Key Influencing Factors},
  journal = {Healthcare and Nursing Practice},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.47297/ppihnp2026020205}
}
Kostenlos starten →